GlassScriptPhysician profile
Peter J Joson
NPI 1578652764
$14,351.82
in general payments reported to CMS, 2019-2025
34 companies · $4,051 in 2025
The $4,051 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,404 · 2020: $1,369 · 2021: $1,567 · 2022: $1,191 · 2023: $2,187 · 2024: $1,583 · 2025: $4,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,249 · Entertainment: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,249.45 |
| Entertainment | $571.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,938.44 | 2019-2025 | Clareon Panoptix Pro, Argos, Tryptyr |
| Abbvie INC. | $2,015.69 | 2022-2025 | |
| Allergan, INC. | $1,570.89 | 2019-2022 | |
| New World Medical,INC. | $1,520.95 | 2019-2025 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Oyster Point Pharma, INC. | $617.29 | 2022-2025 | Tyrvaya |
| Optos, INC. | $571.73 | 2024-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Aerie Pharmaceuticals, INC. | $497.32 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $459.43 | 2023-2025 | Miebo, Envista Envy Iol, Xiidra |
| Glaukos Corporation | $442.41 | 2019-2025 | Idosetr |
| Carl Zeiss Meditec, INC. | $400.00 | 2020 | |
| Nova Eye, INC. | $382.03 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $303.46 | 2019-2025 | Cequa |
| Amgen INC. | $292.79 | 2024-2025 | Tepezza |
| Shire North American Group INC | $274.10 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $255.91 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $248.42 | 2019-2021 | |
| Biotissue Holdings INC. | $224.05 | 2024-2025 | |
| Rxsight INC | $221.66 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Sight Sciences, INC. | $215.12 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Beaver-Visitec International, INC. | $151.70 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $135.58 | 2020-2021 | |
| Horizon Therapeutics Plc | $134.47 | 2022-2023 | Tepezza |
| Genentech USA, INC. | $105.60 | 2021 | |
| Ocular Therapeutix, INC. | $52.02 | 2019-2020 | |
| Dompe US, INC. | $51.00 | 2025 | Oxervate |
| Harrow Eye, LLC | $47.63 | 2024-2025 | Iheezo, Vevye |
| Mallinckrodt Hospital Products INC. | $43.85 | 2023 | Acthar |
| Thea Pharma INC. | $43.70 | 2024-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $40.84 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $31.73 | 2024 | Xdemvy |
| Ani Pharmaceuticals, INC. | $23.38 | 2025 | Purified Cortrophin Gel |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Ivantis, INC | $18.40 | 2019 | |
| Travere Therapeutics, INC. | $0.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Joson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.